PPA 904

Drug Profile

PPA 904

Alternative Names: PPA 904 PDT; PPA 904 photodynamic therapy

Latest Information Update: 23 Jun 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Photopharmica
  • Class Antibacterials; Oxidants; Phenothiazines
  • Mechanism of Action Photosensitisers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Acne; Diabetic foot ulcer; Leg ulcer; Leishmaniasis; Wounds

Most Recent Events

  • 19 Jan 2009 Photopharmica initiates a phase II trial in patients with chronic venous Leg ulcer in United Kingdom
  • 20 Mar 2007 Phase-II clinical trials in Diabetic foot ulcer in United Kingdom (Topical)
  • 20 Mar 2007 Preclinical trials in Acne in United Kingdom (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top